Learn About Plasmacytoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Plasmacytoma Local Doctors?
Elite
Highly rated in
19
conditions

Université De Nantes

Nantes, FR 

Philippe Moreau is in Nantes, France. Moreau is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Bone Marrow Transplant, and Leukemia.

Elite
Highly rated in
25
conditions

University Of Ostrava

Faculty Of Medicine 
Ostrava, MO, CZ 

Roman Hajek is in Ostrava, Czech Republic. Hajek is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. He is also highly rated in 25 other conditions, according to our data. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Monoclonal Gammopathy of Undetermined Significance, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
26
conditions

University Of Bologna

Diagnostic And Specialty Medicine 
Bologna, IT 

Michele Cavo is in Bologna, Italy. Cavo is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. They are also highly rated in 26 other conditions, according to our data. Their top areas of expertise are Multiple Myeloma, Myelofibrosis, Bone Marrow Transplant, and Leukemia.

What are the Latest Advances for Plasmacytoma?
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
Efficacy of ixazomib-lenalidomide-dexamethasone in high-molecular-risk relapsed/refractory multiple myeloma - case series and literature review.
Tired of the same old research?
Check Latest Advances
Clinical analysis of 10 cases with extramedullary plasmacytoma of the head and neck.
What are the latest Plasmacytoma Clinical Trials?
Dysregulation of Hematopoiesis in Fanconi Anemia
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Multicenter, Multi-cohort, Open-label Study of Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide Based Therapy in the First or Second Line Setting.